Limited surgery and conformal photon radiation therapy for pediatric craniopharyngioma: long-term results from the RT1 protocol

被引:20
|
作者
Edmonston, Drucilla Y. [1 ]
Wu, Shengjie [2 ]
Li, Yimei [2 ]
Khan, Raja B. [3 ]
Boop, Frederick A. [4 ]
Merchant, Thomas E. [5 ]
机构
[1] Univ Tennessee, Hlth Sci Ctr, Dept Radiat Oncol, Memphis, TN USA
[2] St Jude Childrens Res Hosp, Dept Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA
[3] St Jude Childrens Res Hosp, Dept Neurol, 332 N Lauderdale St, Memphis, TN 38105 USA
[4] St Jude Childrens Res Hosp, Dept Global Pediat Med, 332 N Lauderdale St, Memphis, TN 38105 USA
[5] St Jude Childrens Res Hosp, Dept Radiat Oncol, 262 Danny Thomas Pl,Mail Stop 210, Memphis, TN 38105 USA
关键词
craniopharyngioma; outcomes; pediatrics; radiotherapy; CHILDHOOD-ONSET; RADIOTHERAPY; MANAGEMENT; RESECTION; SURVIVAL; OUTCOMES; CHILDREN;
D O I
10.1093/neuonc/noac124
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Our aim was to estimate long-term disease control and complications after conformal radiation therapy (CRT) in children and adolescents with craniopharyngioma. Materials and Methods Pediatric patients with craniopharyngioma (n = 101) were enrolled on or treated according to a phase II single institutional protocol from 1998. Surgery was individualized, and CRT (54Gy) was administered using a 1.0 cm or 0.5 cm clinical target volume margin. Patients were followed for 10 years by serial MR imaging and MR angiography and a battery of tests to measure the effects of treatment. Results Twenty patients had tumor progression. Twelve patients who had tumor progression died due to tumor (n = 6) or complications related to tumor or treatment (n = 6). With a median follow-up of 14.94 years for survivors, the 10 year estimates (+/- SE) of progression-free survival (PFS), event-free survival (EFS), and overall survival (OS) were 78.84% +/- 4.10%, 77.12% +/- 4.19%, and 96.02% +/- 1.95%, respectively. OS, EFS, and PFS were significantly associated with race, shunt status, and tumor volume. The 10 year cumulative incidence (+/- SE) of the secondary tumor (1.99% +/- 1.40%), secondary malignant tumor (1.0% +/- 1.0%), necrosis (1.98% +/- 1.39%), vasculopathy (8.47% +/- 2.90%), and permanent neurologic deficits (8.28% +/- 3.37%) were estimated by competing risk analysis. Three patients required revascularization surgery. Salvage therapy was successful in 13 patients using surgery and radiosurgery. Conclusions Limited surgery and CRT using photons results in excellent tumor control. Tumor control and the incidence and severity of complications are associated with host, tumor, and treatment factors.
引用
收藏
页码:2200 / 2209
页数:10
相关论文
共 50 条
  • [1] Limited Surgery and Conformal Photon Radiation Therapy for Pediatric Craniopharyngioma: Long-Term Results From the RT1 Protocol
    Edmonston, D.
    Wu, S.
    Li, Y.
    Khan, R. B.
    Boop, F. A.
    Merchant, T. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S84 - S84
  • [2] CRANIOPHARYNGIOMA - LONG-TERM RESULTS FOLLOWING LIMITED SURGERY AND RADIOTHERAPY
    RAJAN, B
    ASHLEY, S
    GORMAN, C
    JOSE, CC
    HORWICH, A
    BLOOM, HJG
    MARSH, H
    BRADA, M
    RADIOTHERAPY AND ONCOLOGY, 1993, 26 (01) : 1 - 10
  • [3] Pediatric Craniopharyngioma: The Effect of Visual Deficits and Hormone Deficiencies on Long-Term Cognitive Outcomes After Conformal Photon Radiation Therapy
    Merchant, Thomas E.
    Dangda, Sonal
    Hoehn, Mary Ellen
    Wu, Shengjie
    Li, Yimei
    Wang, Fang
    Pan, Haitao
    Boop, Frederick A.
    Jurbergs, Niki
    Conklin, Heather M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 115 (03): : 581 - 591
  • [4] Efficacy and Safety of Limited -Margin Conformal Radiation Therapy for Pediatric Rhabdomyosarcoma: Long -Term Results of a Phase 2
    Tinkle, Christopher L.
    Pappo, Alberto
    Wu, Jianrong
    Mao, Shenghua
    Hua, Chia-ho
    Shulkin, Barry L.
    McCarville, M. Beth
    Kaste, Sue C.
    Davidoff, Andrew M.
    Bahrami, Armita
    Green, Daniel M.
    Ness, Kirsten K.
    Merchant, Thomas E.
    Spunt, Sheri L.
    Krasin, Matthew J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 107 (01): : 172 - 180
  • [5] Long-Term Outcome of Surgery and Radiation Treatment for Craniopharyngioma
    Poiset, S. J.
    Ali, A.
    Cappelli, L.
    Shah, Y. B.
    Zhan, T.
    Evans, J.
    Shi, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E47 - E47
  • [6] Long-term results with radiation therapy for pediatric desmoid tumors
    Merchant, TE
    Nguyen, D
    Walter, AW
    Pappo, AS
    Kun, LE
    Rao, BN
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (05): : 1267 - 1271
  • [7] Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma
    Greenfield, Brad J.
    Okcu, Mehmet F.
    Baxter, Patricia A.
    Chintagumpala, Murali
    Teh, Bin S.
    Dauser, Robert C.
    Su, Jack
    Desai, Snehal S.
    Paulino, Arnold C.
    RADIOTHERAPY AND ONCOLOGY, 2015, 114 (02) : 224 - 229
  • [8] PEDIATRIC CRANIOPHARYNGIOMAS - LONG-TERM RESULTS OF COMBINED TREATMENT WITH SURGERY AND RADIATION
    REGINE, WF
    KRAMER, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 24 (04): : 611 - 617
  • [9] Long-term outcomes for adult craniopharyngioma following radiation therapy
    Masson-Cote, Laurence
    Masucci, Giuseppina Laura
    Atenafu, Eshetu G.
    Millar, Barbara-Ann
    Cusimano, Michael
    Croul, Sidney
    Mason, Warren
    Laperriere, Normand J.
    Sahgal, Arjun
    ACTA ONCOLOGICA, 2013, 52 (01) : 153 - 158
  • [10] Long-Term Outcomes of Surgery and Radiation Treatment for Adult Patients with Craniopharyngioma
    Poiset, Spencer J.
    Song, Andrew
    Yoon, Hong In
    Huang, Jiayi
    Jain, Shray
    Palmer, Joshua D.
    Matsui, Jennifer K.
    Cappelli, Louis
    Mazza, Jacob M.
    Ali, Ayesha S.
    Evans, James J.
    Farrell, Christopher J.
    Kearns, Kathryn N.
    Sheehan, Jason P.
    Shi, Wenyin
    WORLD NEUROSURGERY, 2024, 187 : E852 - E859